SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5clw'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1D4F_C_ADNC603_1
(S-ADENOSYLHOMOCYSTEI
NE HYDROLASE)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		5 / 12 LEU A 525
HIS A 528
LEU A 597
GLY A 531
PHE A 625
 None
 1.40A 1d4fC-5clwA:
undetectable		 1d4fC-5clwA:
20.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1W5U_B_DVAB6_0
(GRAMICIDIN D)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		3 / 3 TRP A 548
ALA A 483
VAL A 485
 None
 0.95A 1w5uA-5clwA:
undetectable
1w5uB-5clwA:
undetectable		 1w5uA-5clwA:
2.52
1w5uB-5clwA:
2.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2IZQ_A_DVAA6_0
(GRAMICIDIN D)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		3 / 3 ALA A 483
VAL A 485
TRP A 548
 None
 0.94A 2izqA-5clwA:
undetectable
2izqB-5clwA:
undetectable		 2izqA-5clwA:
2.52
2izqB-5clwA:
2.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2IZQ_D_DVAD6_0
(GRAMICIDIN D)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		3 / 3 TRP A 548
ALA A 483
VAL A 485
 None
 0.89A 2izqC-5clwA:
undetectable
2izqD-5clwA:
undetectable		 2izqC-5clwA:
2.52
2izqD-5clwA:
2.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2NNH_B_9CRB502_1
(CYTOCHROME P450 2C8)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		5 / 10 ILE A  55
ILE A  59
LEU A 395
ASN A 397
ILE A 424
 None
 1.15A 2nnhB-5clwA:
undetectable		 2nnhB-5clwA:
21.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QWX_A_ML1A233_1
(RIBOSYLDIHYDRONICOTI
NAMIDE DEHYDROGENASE
[QUINONE])		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		4 / 8 ILE A 439
PHE A 616
GLY A 532
ILE A 474
 None
 0.94A 2qwxA-5clwA:
undetectable
2qwxB-5clwA:
undetectable		 2qwxA-5clwA:
15.84
2qwxB-5clwA:
15.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CO4_A_GCSA401_1
(CHITINASE)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		3 / 3 GLU A 271
HIS A 277
HIS A 188
 None
 0.91A 3co4A-5clwA:
4.7		 3co4A-5clwA:
16.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3E23_A_SAMA221_1
(UNCHARACTERIZED
PROTEIN RPA2492)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		3 / 3 TYR A 200
ASP A 584
HIS A 545
 None
 0.95A 3e23A-5clwA:
undetectable		 3e23A-5clwA:
16.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3GLQ_A_RABA602_1
(ADENOSYLHOMOCYSTEINA
SE)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		5 / 12 LEU A 525
HIS A 528
LEU A 597
GLY A 531
PHE A 625
 None
 1.27A 3glqA-5clwA:
undetectable		 3glqA-5clwA:
20.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3GLQ_B_RABB602_1
(ADENOSYLHOMOCYSTEINA
SE)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		5 / 12 LEU A 525
HIS A 528
LEU A 597
GLY A 531
PHE A 625
 None
 1.27A 3glqB-5clwA:
undetectable		 3glqB-5clwA:
20.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3L8L_B_DVAB6_0
(GRAMICIDIN D)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		3 / 3 TRP A 548
ALA A 483
VAL A 485
 None
 0.95A 3l8lA-5clwA:
undetectable
3l8lB-5clwA:
undetectable		 3l8lA-5clwA:
2.52
3l8lB-5clwA:
3.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3L8L_D_DVAD6_0
(GRAMICIDIN D)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		3 / 3 TRP A 548
ALA A 483
VAL A 485
 None
 0.89A 3l8lC-5clwA:
undetectable
3l8lD-5clwA:
undetectable		 3l8lC-5clwA:
2.52
3l8lD-5clwA:
3.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QEL_D_QELD2_1
(NMDA GLUTAMATE
RECEPTOR SUBUNIT
GLUTAMATE [NMDA]
RECEPTOR SUBUNIT
EPSILON-2)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		4 / 5 TYR A 433
THR A 409
ARG A 355
LEU A 435
 None
 1.29A 3qelC-5clwA:
undetectable		 3qelC-5clwA:
20.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E1G_B_LNLB701_1
(PROSTAGLANDIN G/H
SYNTHASE 2)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		5 / 12 ARG A 226
PHE A 551
PHE A 249
PHE A 538
GLY A 540
 None
 0.97A 4e1gB-5clwA:
undetectable		 4e1gB-5clwA:
21.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4IG5_A_MMZA616_1
(LACTOPEROXIDASE)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		4 / 5 GLN A 566
HIS A 545
ARG A 565
LEU A 569
 None
 1.47A 4ig5A-5clwA:
undetectable		 4ig5A-5clwA:
20.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4IG5_B_MMZB617_1
(LACTOPEROXIDASE)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		4 / 5 GLN A 566
HIS A 545
ARG A 565
LEU A 569
 None
 1.47A 4ig5B-5clwA:
undetectable		 4ig5B-5clwA:
20.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM4_A_8PRA603_1
(TRANSPORTER)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		5 / 12 VAL A 145
TYR A 155
PHE A 110
SER A 148
GLY A  97
 None
 1.33A 4mm4A-5clwA:
undetectable		 4mm4A-5clwA:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM7_A_29JA603_1
(TRANSPORTER)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		5 / 10 VAL A 145
TYR A 155
PHE A 110
SER A 148
GLY A  97
 None
 1.31A 4mm7A-5clwA:
undetectable		 4mm7A-5clwA:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MMC_A_29JA603_1
(TRANSPORTER)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		5 / 10 VAL A 145
TYR A 155
PHE A 110
SER A 148
GLY A  97
 None
 1.35A 4mmcA-5clwA:
undetectable		 4mmcA-5clwA:
22.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4O4D_A_ACTA406_0
(INOSITOL
HEXAKISPHOSPHATE
KINASE)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		4 / 7 ASP A 274
THR A 275
PHE A 186
HIS A 188
 None
 1.46A 4o4dA-5clwA:
undetectable		 4o4dA-5clwA:
15.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4O7G_A_ASCA303_0
(PROBABLE
TRANSMEMBRANE
ASCORBATE
FERRIREDUCTASE 2)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		4 / 7 PHE A 249
HIS A 203
ILE A 206
ASN A 541
 None
 1.31A 4o7gA-5clwA:
undetectable
4o7gB-5clwA:
undetectable		 4o7gA-5clwA:
14.91
4o7gB-5clwA:
14.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OLT_A_GCSA303_1
(CHITOSANASE)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		4 / 6 ASP A 286
ARG A 355
GLY A 358
HIS A 480
 None
 1.07A 4oltA-5clwA:
undetectable		 4oltA-5clwA:
17.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OLT_B_GCSB303_1
(CHITOSANASE)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		4 / 6 ASP A 286
ARG A 355
GLY A 358
HIS A 480
 None
 1.06A 4oltB-5clwA:
undetectable		 4oltB-5clwA:
17.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4PGF_A_ADNA502_1
(ADENOSYLHOMOCYSTEINA
SE)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		5 / 12 LEU A 525
HIS A 528
LEU A 597
GLY A 531
PHE A 625
 None
 1.24A 4pgfA-5clwA:
undetectable		 4pgfA-5clwA:
20.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QYQ_A_3CJA607_1
(LACTOPEROXIDASE)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		3 / 3 GLN A 566
HIS A 545
ARG A 565
 None
 1.20A 4qyqA-5clwA:
undetectable		 4qyqA-5clwA:
20.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QYQ_B_3CJB607_1
(LACTOPEROXIDASE)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		3 / 3 GLN A 566
HIS A 545
ARG A 565
 None
 1.18A 4qyqB-5clwA:
undetectable		 4qyqB-5clwA:
20.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5CLT_A_ACRA1000_1
(1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		10 / 10 ASN A  62
GLU A  63
TRP A  91
PRO A  93
TYR A 119
GLY A 120
LYS A 121
TRP A 332
GLU A 333
ARG A 336
 GLC  A1004 ( 3.2A)
GLC  A1004 ( 3.4A)
GLC  A1006 ( 3.8A)
GLC  A1007 ( 4.0A)
GLC  A1005 ( 3.8A)
GLC  A1007 ( 3.7A)
GLC  A1005 ( 2.9A)
GLC  A1005 ( 4.8A)
GLC  A1005 ( 3.5A)
GLC  A1005 ( 4.3A)
 0.32A 5cltA-5clwA:
64.8		 5cltA-5clwA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5CLT_B_ACRB1000_1
(1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		10 / 10 ASN A  62
GLU A  63
TRP A  91
PRO A  93
TYR A 119
GLY A 120
LYS A 121
TRP A 332
GLU A 333
ARG A 336
 GLC  A1004 ( 3.2A)
GLC  A1004 ( 3.4A)
GLC  A1006 ( 3.8A)
GLC  A1007 ( 4.0A)
GLC  A1005 ( 3.8A)
GLC  A1007 ( 3.7A)
GLC  A1005 ( 2.9A)
GLC  A1005 ( 4.8A)
GLC  A1005 ( 3.5A)
GLC  A1005 ( 4.3A)
 0.36A 5cltB-5clwA:
67.0		 5cltB-5clwA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5CLT_C_ACRC1000_1
(1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		10 / 10 ASN A  62
GLU A  63
TRP A  91
PRO A  93
TYR A 119
GLY A 120
LYS A 121
TRP A 332
GLU A 333
ARG A 336
 GLC  A1004 ( 3.2A)
GLC  A1004 ( 3.4A)
GLC  A1006 ( 3.8A)
GLC  A1007 ( 4.0A)
GLC  A1005 ( 3.8A)
GLC  A1007 ( 3.7A)
GLC  A1005 ( 2.9A)
GLC  A1005 ( 4.8A)
GLC  A1005 ( 3.5A)
GLC  A1005 ( 4.3A)
 0.29A 5cltC-5clwA:
66.1		 5cltC-5clwA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EAJ_B_FOLB201_1
(DIHYDROFOLATE
REDUCTASE)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		3 / 3 ASP A 573
ARG A 226
ARG A 585
 None
 0.95A 5eajB-5clwA:
undetectable		 5eajB-5clwA:
13.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FF1_A_MMZA601_1
(LACTOPEROXIDASE)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		4 / 5 GLN A 566
HIS A 545
ARG A 565
LEU A 569
 None
 1.45A 5ff1A-5clwA:
1.0		 5ff1A-5clwA:
20.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FF1_A_MMZA602_1
(LACTOPEROXIDASE)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		4 / 5 GLN A 566
HIS A 545
ARG A 565
LEU A 569
 None
 1.45A 5ff1A-5clwA:
1.0		 5ff1A-5clwA:
20.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FF1_B_MMZB601_1
(LACTOPEROXIDASE)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		4 / 5 GLN A 566
HIS A 545
ARG A 565
LEU A 569
 None
 1.45A 5ff1B-5clwA:
undetectable		 5ff1B-5clwA:
20.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FF1_B_MMZB613_1
(LACTOPEROXIDASE)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		4 / 5 GLN A 566
HIS A 545
ARG A 565
LEU A 569
 None
 1.45A 5ff1B-5clwA:
undetectable		 5ff1B-5clwA:
20.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IGV_A_ZITA404_1
(MACROLIDE
2'-PHOSPHOTRANSFERAS
E II)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		5 / 12 GLY A 358
TYR A 251
HIS A 480
ALA A 239
ILE A 410
 None
 1.13A 5igvA-5clwA:
2.4		 5igvA-5clwA:
19.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5N5D_A_SAMA306_1
(METHYLTRANSFERASE)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		4 / 7 SER A 255
ILE A 176
ASP A 298
ASN A 170
 None
 0.93A 5n5dA-5clwA:
undetectable		 5n5dA-5clwA:
16.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6A93_B_8NUB3001_1
(5-HYDROXYTRYPTAMINE
RECEPTOR 2A,SOLUBLE
CYTOCHROME B562)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		4 / 5 ASP A 286
ILE A 206
PHE A 551
TYR A 251
 None
 1.08A 6a93B-5clwA:
undetectable		 6a93B-5clwA:
20.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6APH_A_ADNA501_1
(ADENOSYLHOMOCYSTEINA
SE)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		5 / 12 LEU A 525
HIS A 528
LEU A 597
GLY A 531
PHE A 625
 None
 1.20A 6aphA-5clwA:
undetectable		 6aphA-5clwA:
20.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6BXL_A_SAMA401_0
(2-(3-AMINO-3-CARBOXY
PROPYL)HISTIDINE
SYNTHASE)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		5 / 12 HIS A 203
SER A 324
GLN A 252
VAL A 288
ASP A 286
 None
 1.25A 6bxlA-5clwA:
undetectable		 6bxlA-5clwA:
19.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6BXL_B_SAMB401_0
(2-(3-AMINO-3-CARBOXY
PROPYL)HISTIDINE
SYNTHASE)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		5 / 12 HIS A 203
SER A 324
GLN A 252
VAL A 288
ASP A 286
 None
 1.38A 6bxlB-5clwA:
undetectable		 6bxlB-5clwA:
19.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DJZ_A_GMJA301_0
(SIGMA NON-OPIOID
INTRACELLULAR
RECEPTOR 1)		 5clw 1,4-ALPHA-GLUCAN-BRA
NCHING ENZYME
(Homo
sapiens) 		5 / 12 LEU A 663
THR A 640
VAL A 638
ALA A 692
TYR A 657
 None
 1.13A 6djzA-5clwA:
undetectable		 6djzA-5clwA:
16.29